| Filed On | Filing |
|---|---|
| 29 Oct 2026 | 10-Q |
| 29 Oct 2026 |
8-K: Results of Operations and Financial Condition; Other Events
DEERFIELD, Ill., OCT. 29, 2026 – Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the third quarter of 2026. |
| 27 Oct 2026 | SCHEDULE 13G/A |
| 02 Oct 2026 |
Form 3: Rogers Terence John, EVP and CFO
Holds 0 shares of Common Stock, $1 par value |
| 18 Sep 2026 |
Form 3: Heine Bernard, AVP, Finance InterimCAO&Cntrlr
Holds 32,840 shares of Common Stock, $1 par value |
| 03 Sep 2026 |
Form 4: Teaff James, President, CCS
Gave up 750 shares to cover exercise price or tax ($19.1K) |
| 03 Sep 2026 |
Form 4: Hider Andrew P., Director
Gave up 54,276 shares to cover exercise price or tax ($1.39M) |
| 03 Sep 2026 |
Form 4: Foster Julie, President, Front Line Care
Gave up 2,098 shares to cover exercise price or tax ($53.9K) |
| 19 Aug 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
We are pleased to welcome you to Baxter International Inc. (“Baxter” or the “Company”) and to confirm our verbal offer of employment, subject to formal approval by the Board of Directors of Baxter (the “Board”). This is where your purpos... |
| 18 Aug 2026 |
8-K: Entry into a Material Definitive Agreement; Other Events
AMENDMENT NO. 2, dated as of August 18, 2026 (this “Amendment”), among Baxter International Inc., a Delaware corporation (the “Borrower Representative”), Baxter Healthcare SA (the “Swiss Borrower” and, together with Borrower Representati... |
| 04 Aug 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On July 31, 2026, Anita Zielinski notified Baxter International Inc. (the “Company”) of her decision to resign as the Company’s Interim Chief Financial Officer and Senior Vice President, Chief Accounting Officer and Controller, effective... |
| 04 Aug 2026 |
8-K: Other Events
DEERFIELD, Ill., Aug. 4, 2026 - Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced that it has commenced cash tender offers (each, an “Offer” and collectively, the “Offers”) for the maximum principal amount ... |
| 30 Jul 2026 | 10-Q |
| 30 Jul 2026 |
8-K: Results of Operations and Financial Condition; Other Events
DEERFIELD, Ill., JULY 30, 2026 – Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the second quarter of 2026. |
| 14 Jul 2026 |
8-K: Regulation FD Disclosure
The following tables present our U.S. and international disaggregated net sales. |
| 05 Jun 2026 | SCHEDULE 13G/A |
| 03 Jun 2026 |
Form 4: Zielinski Anita A, SVP, Interim CFO, CAO & Cntrlr
Received 13,426 shares as a grant or award |
| 03 Jun 2026 |
Form 4: Wallace Steven P., President, Adv. Surgery
Gave up 153 shares to cover exercise price or tax ($2.86K) |
| 03 Jun 2026 |
Form 4: Teaff James, President, CCS
Gave up 321 shares to cover exercise price or tax ($6K) |
| 29 May 2026 | SD |
Loading...